The most common combinations of PD medications in the overall population were levodopa +dopamine agonist + MAO-B inhibitor (14.3%), followed by levodopa + dopamine agonist (13.7%) and levodopa + MAO-B inhibitor (9.1%). The gene discussed is MAOB; the disease is Parkinson disease.